FTC Gives Final OK To Endo's $8B Par Pharmaceutical Buy
Endo International PLC cleared the final hurdle to its $8 billion acquisition of Par Pharmaceutical Inc. on Thursday when the Federal Trade Commission granted final approval to the companies' plan to...To view the full article, register now.
Already a subscriber? Click here to view full article